Predict your next investment

CirculoGene Diagnostics company logo
HEALTHCARE | Disease Diagnosis
circulogene.com

See what CB Insights has to offer

Founded Year

2015

Stage

Loan | Alive

Total Raised

$6.79M

Last Raised

$680K | 2 yrs ago

About CirculoGene Diagnostics

Circulogene is a personalized medicine company that is developing a "liquid biopsy" that is based on the discovery that as tumors grow, they also die, releasing their DNA into the bloodstream. Circulogene's liquid biopsy tumor DNA sequencing is a test that aims to combine finger-stick volumes of blood and next-generation sequencing (NGS) to monitor tumor-mutant DNA within well-characterized, well-documented, cancer-associated genes.

CirculoGene Diagnostics Headquarter Location

3125 Independence Drive Suite 301

Birmingham, Alabama, 35209,

United States

855-614-7083

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing CirculoGene Diagnostics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned CirculoGene Diagnostics in 1 CB Insights research brief, most recently on Oct 10, 2019.

Expert Collections containing CirculoGene Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CirculoGene Diagnostics is included in 4 Expert Collections, including Cancer.

C

Cancer

3,710 items

Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

11,293 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

CirculoGene Diagnostics Patents

CirculoGene Diagnostics has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/12/2016

5/25/2021

Molecular biology, Oncology, Genetics, Biotechnology, DNA

Grant

Application Date

8/12/2016

Grant Date

5/25/2021

Title

Related Topics

Molecular biology, Oncology, Genetics, Biotechnology, DNA

Status

Grant

CirculoGene Diagnostics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CirculoGene Diagnostics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.